[HTML][HTML] Ascites promotes cell migration through the repression of miR-125b in ovarian cancer

L Yang, X Zhang, Y Ma, X Zhao, B Li, H Wang - Oncotarget, 2017 - ncbi.nlm.nih.gov
L Yang, X Zhang, Y Ma, X Zhao, B Li, H Wang
Oncotarget, 2017ncbi.nlm.nih.gov
Interactions between ovarian cancer cells and the surrounding tumor microenvironment are
not well characterized. Here, we investigated the molecular mechanisms by which malignant
ascites promote the metastasis of ovarian cancer. It was found that ovarian cancer ascites
promoted ovarian cancer cell migration which was attenuated by either heat inactivation or
antibody blockade of TGF-β. High level (at ng/ml level) of TGF-β was detected in the ascites.
In addition, ascites repressed the expression of miRNA-125b in a TGF-β-dependent manner …
Abstract
Interactions between ovarian cancer cells and the surrounding tumor microenvironment are not well characterized. Here, we investigated the molecular mechanisms by which malignant ascites promote the metastasis of ovarian cancer. It was found that ovarian cancer ascites promoted ovarian cancer cell migration which was attenuated by either heat inactivation or antibody blockade of TGF-β. High level (at ng/ml level) of TGF-β was detected in the ascites. In addition, ascites repressed the expression of miRNA-125b in a TGF-β-dependent manner. Mimic of miR-125b blocked ascites-induced cell migration. Furthermore, Gab2 (a target gene of miR-125b) was elevated by ascites in a TGF-β-dependent manner. And forced expression of Gab2 reversed the inhibition of migration induced by miR-125b mimic. Most importantly, the expression of miR-125b and Gab2 mRNA was negatively correlated in ovarian cancer specimens. Taken together, our finding suggested that TGF-β in ascites promoted cancer cell migration through repression of miR-125b in ovarian cancer. This might provide a novel therapeutic target for ovarian cancer in the future.
ncbi.nlm.nih.gov